The Nordic and Northern European region is still widely regarded as a very attractive location to run clinical studies. Such countries are internationally regarded for their exceptionally high-quality healthcare systems, which are well funded, with a strong infrastructure, highly trained medical personnel and a rich academic tradition. However like other Western European countries, clinical site saturation is becoming an important issue in this region as the number of studies increase, as well as their complexity. Nordic and Northern European countries must maintain their competitive edge in contrast to other emerging clinical regions with larger, treatment naive patient populations. This event will bring together the regions clinical Key Opinion Leaders to discuss and share what is now required, specifically: fresh perspectives, innovative ideas and new approaches.
This conference offers a rare opportunity for the clinical trial industry in Nordic and Northern European countries to come together, understand and develop a best-practice approach to site selection and increasing patient recruitment performance. It will be a unique chance for pharma, biotech, medical device and other clinical trial sponsors, CROs, principal investigators, ethics committees and regulatory drug agencies to benchmark, share experiences, network and drive forward partnerships. All participants will walk away with a greater understanding of how to take advantage of this dynamic region, whether running studies in-house or through clinical outsourcing partnerships.
For further information and registration, please visit: